| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.1M | +0.2% |
| Cost of Revenue | $4.0M | +7.1% |
| R&D Expense | $684K | +4.1% |
| SG&A Expense | $3.5M | +0.5% |
| Operating Income | -$267K | -292.6% |
| Interest Expense | $151K | +4.1% |
| Pre-tax Income | -$418K | -100.0% |
| Income Tax | $0 | — |
| Net Income | -$418K | -100.0% |
| EPS (Basic) | -$0.05 | -66.7% |
| EPS (Diluted) | -$0.05 | -66.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $723K | -31.7% |
| Inventory | $1.5M | +31.8% |
| Current Assets | $3.4M | -4.2% |
| Total Assets | $4.8M | -6.8% |
| Current Liabilities | $4.6M | -2.3% |
| Total Liabilities | $4.6M | -4.7% |
| Stockholders' Equity | -$4.1M | -3.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8K | -38.5% |
| Capital Expenditures | $43K | -74.1% |
| Investing Cash Flow | -$45K | +73.7% |
| Financing Cash Flow | -$200K | +0.0% |
| Free Cash Flow | -$35K | +77.1% |